These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36621078)

  • 41. New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic.
    Perry BL; Odabaş M; Yang KC; Lee B; Kaminski P; Aronson B; Ahn YY; Oser CB; Freeman PR; Talbert JC
    Addiction; 2022 Jan; 117(1):195-204. PubMed ID: 34227707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning.
    Nateghi Haredasht F; Fouladvand S; Tate S; Chan MM; Yeow JJL; Griffiths K; Lopez I; Bertz JW; Miner AS; Hernandez-Boussard T; Chen CA; Deng H; Humphreys K; Lembke A; Vance LA; Chen JH
    Addiction; 2024 Oct; 119(10):1792-1802. PubMed ID: 38923168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Performance of a Gene-Based Machine Learning Classifier in Assessing Risk of Developing OUD in Subjects Taking Oral Opioids: A Prospective Observational Study.
    Donaldson K; Cardamone D; Genovese M; Garbely J; Demers L
    Ann Clin Lab Sci; 2021 Jul; 51(4):451-460. PubMed ID: 34452883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020.
    Durand L; Keenan E; O'Reilly D; Bennett K; O'Hara A; Cousins G
    BMC Psychiatry; 2023 Oct; 23(1):725. PubMed ID: 37803285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System - United States, 2014-2017.
    García MC; Heilig CM; Lee SH; Faul M; Guy G; Iademarco MF; Hempstead K; Raymond D; Gray J
    MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(2):25-30. PubMed ID: 30653483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deep Learning Solutions for Classifying Patients on Opioid Use.
    Che Z; St Sauver J; Liu H; Liu Y
    AMIA Annu Symp Proc; 2017; 2017():525-534. PubMed ID: 29854117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using Electronic Medical Records and Clinical Notes to Predict the Outcome of Opioid Treatment Program.
    Cui W; Shah-Mohammadi F; Finkelstein J
    Stud Health Technol Inform; 2023 Jun; 305():568-571. PubMed ID: 37387094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Machine learning algorithms predict extended postoperative opioid use in primary total knee arthroplasty.
    Klemt C; Harvey MJ; Robinson MG; Esposito JG; Yeo I; Kwon YM
    Knee Surg Sports Traumatol Arthrosc; 2022 Aug; 30(8):2573-2581. PubMed ID: 34984528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining structured and unstructured data for predictive models: a deep learning approach.
    Zhang D; Yin C; Zeng J; Yuan X; Zhang P
    BMC Med Inform Decis Mak; 2020 Oct; 20(1):280. PubMed ID: 33121479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automatically identifying opioid use disorder in non-cancer patients on chronic opioid therapy.
    Zhu VJ; Lenert LA; Barth KS; Simpson KN; Li H; Kopscik M; Brady KT
    Health Informatics J; 2022; 28(2):14604582221107808. PubMed ID: 35726687
    [No Abstract]   [Full Text] [Related]  

  • 53. Automated prediction of risk for problem opioid use in a primary care setting.
    Hylan TR; Von Korff M; Saunders K; Masters E; Palmer RE; Carrell D; Cronkite D; Mardekian J; Gross D
    J Pain; 2015 Apr; 16(4):380-7. PubMed ID: 25640294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of opioid-related outcomes in a medicaid surgical population: Evidence to guide postoperative opiate therapy and monitoring.
    El Hajouji O; Sun RS; Zammit A; Humphreys K; Asch SM; Carroll I; Curtin CM; Hernandez-Boussard T
    PLoS Comput Biol; 2023 Aug; 19(8):e1011376. PubMed ID: 37578969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
    Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
    J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using natural language processing to identify problem usage of prescription opioids.
    Carrell DS; Cronkite D; Palmer RE; Saunders K; Gross DE; Masters ET; Hylan TR; Von Korff M
    Int J Med Inform; 2015 Dec; 84(12):1057-64. PubMed ID: 26456569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
    Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
    Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prescription History Before Opioid Overdose Death: PDMP Data and Responsible Prescribing.
    Shreffler J; Shaw I; Berrones A; Huecker M
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):385-392. PubMed ID: 32810066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for the development of opioid use disorder after first opioid prescription: a Swedish national study.
    Kendler KS; Lönn SL; Ektor-Andersen J; Sundquist J; Sundquist K
    Psychol Med; 2023 Oct; 53(13):6223-6231. PubMed ID: 36415073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.